Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
53,583,544
-
Total 13F shares
-
28,750,213
-
Share change
-
-1,446,977
-
Total reported value
-
$181,703,500
-
Put/Call ratio
-
7.3%
-
Price per share
-
$6.32
-
Number of holders
-
54
-
Value change
-
-$8,991,867
-
Number of buys
-
27
-
Number of sells
-
23
Institutional Holders of ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) as of Q3 2024
As of 30 Sep 2024,
ABEONA THERAPEUTICS INC. - Common Stock, par value $0.01 per share (ABEO) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,750,213 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, Nantahala Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Vivo Capital, LLC, Rosalind Advisors, Inc., Western Standard LLC, Laurion Capital Management LP, and Walleye Capital LLC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.